UNSPSC 51144120: Fenproporex

This classification denotes an anorexiant with the molecular formula C12H16N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) W0194S5FOA, chemically known as propionitrile, 3-((alpha-methylphenethyl)amino)-, (+-)- but more generally known as fenproporex, which bears US NIH Compound Identifier 61810. European Medicines Agency schedules Fenproporex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07592MIG. The term FENPROPOREX is an International Non-Proprietary Name.

UNSPSC 51144120 Fenproporex (Commodity) describes pharmaceutical and chemical compounds procured by state and local health and safety agencies, though recent solicitation activity shows the code capturing purchases of naloxone and drug deactivation systems rather than fenproporex specifically. State and local buyers under this code include county health departments and community health initiatives. Seminole County, Florida has emerged as a recent active purchaser, seeking naloxone and related harm-reduction products to support public health objectives.

Seminole County, Florida represents the primary recent geographic activity under this code. On June 30, 2026, Seminole County issued IFB 60459723LAS seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries required to the Seminole County Community Health Building in Sanford, Florida and a response deadline of July 26, 2023. The contract carries a two-year initial term with a one-year renewal option, fixed-fee pricing, E-Verify compliance requirements, and potential FEMA funding with associated federal environmental and compliance obligations. Vendors must include all shipping and delivery costs in their proposals and maintain workers' compensation, commercial general liability, and professional liability insurance.